During the past decade, Intermountain Hematology/Oncology Associates, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Intermountain Hematology/Oncology Associates, Inc." #1 sponsor was "Celgene Corporation" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intermountain Hematology/Oncology Associates, Inc." #1 collaborator was "Prologue Research International" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Intermountain Hematology/Oncology Associates, Inc." are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Lymphoma" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Intermountain Hematology/Oncology Associates, Inc." in a lesser frequency.

Most popular intervention types in "Intermountain Hematology/Oncology Associates, Inc." are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "5-Fluorouracil (5-FU)" (1 trials), "Capecitabine" (1 trials), "FOLFOX regimen" (1 trials) and "Leucovorin (LV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intermountain Hematology/Oncology Associates, Inc." are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Intermountain Hematology/Oncology Associates, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Intermountain Hematology/Oncology Associates, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intermountain Hematology/Oncology Associates, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".